Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based Biomarkers, Treatment and Outcome

ConditionsSquamous Cell Carcinoma of the Oral Cavity Squamous Cell Carcinoma of the Oropharynx Squamous Cell Carcinoma of the Hypopharynx Squamous Cell Carcinoma of the Larynx

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorAIO-Studien-gGmbH

About this trial

Prospective, open, non-interventional, multi-center clinical registry study with the aim to establish a comprehensive research platform reflecting the real-world treatment landscape for recurrent/metastatic head and neck tumor patients.

Eligibility criteria

Qualifiers

Age ≥ 18 years

Able to understand and willing to sign written informed consent

Histologically or cytologically confirmed squamous cell carcinoma of the head and neck (oral cavity, oropharynx, hypopharynx or larynx)

Patients not amenable for curative treatment who receive palliative systemic treatment or best supportive care

Disqualifiers

None

Trial design

Treatments tested in this trial

data collection

Treatment groups

No treatment groups listed

Locations

Universitätsklinikum Essen45147, Essen Germany

Onkologie/Studienzentrum am Raschplatz GbR30161, Hanover Germany

Sponsors and collaborators

AIO-Studien-gGmbH

Lead sponsor

Merck Sharp & Dohme LLC

Collaborator

Source ClinicalTrials.gov